RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Hereditary Haemorrhagic Telangiectasia: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Integrating Hereditary Hemorrhagic Telangiectasia into the Diagnostic Workup of Adolescent Heavy Menstrual Bleeding.
Carter-Febres Maria et al., Pediatric blood & cancer (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42872963/
- 2.
Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia.
Al-Samkari Hanny, The Lancet. Haematology (11 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42860130/
- 3.
Determinants of quality of life in hereditary haemorrhagic telangiectasia: the relative roles of bleeding, anaemia and visceral involvement
Pernille Darre Haahr et al., Orphanet Journal of Rare Diseases (6 October 2026)
https://doi.org/10.1186/s13023-026-04643-5
- 4.
Beyond the Black Box: Physics-Based and Conservation-Informed Evidence for ACVRL1 Variant Classification in Hereditary Hemorrhagic Telangiectasia and Pulmonary Arterial Hypertension
Klaus Brusgaard, Preprints.org (4 October 2026)
https://doi.org/10.20944/preprints202610.0157.v1
- 5.
Natural history of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a longitudinal neuroimaging study and review of the literature.
Li Boyi et al., Neuroradiology (2 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42825815/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
NCT07623525 · Recruiting · Phase 1 / Phase 2 · Diagonal Therapeutics, Inc.
Ages 18 and over
https://clinicaltrials.gov/study/NCT07623525
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Hereditary Haemorrhagic Telangiectasia
Hereditary haemorrhagic telangiectasia is an inherited condition in which blood vessels form abnormally. Small vessels on the skin and lining of the nose and gut are fragile and bleed easily, causing frequent nosebleeds and anaemia. Larger vessel malformations can occur in the lungs, brain and liver. Care involves regular screening, bleeding control and treatment of the malformations.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
To understand the effect of hereditary hemorrhagic telangiectasis (HHT) on uterine bleeding is paramount to improving clinical care of menstruating individuals with HHT. Heavy menstrual bleeding (HMB) in adolescents and young adults (AYAs) with HHT is underrecognized and among individuals with HMB, HHT should be considered in the differential diagnosis, especially among those with suggestive clinical features or family history. Stigmatization associated with vaginal blood loss likely contributes to the paucity of evidence to guide HMB management in individuals with HHT, as previously reported in von Willebrand disease and other inherited bleeding disorders.
Common Questions
What is Hereditary Haemorrhagic Telangiectasia?
Hereditary haemorrhagic telangiectasia is an inherited condition in which blood vessels form abnormally. Small vessels on the skin and lining of the nose and gut are fragile and bleed easily, causing frequent nosebleeds and anaemia. Larger vessel malformations can occur in the lungs, brain and liver. Care involves regular screening, bleeding control and treatment of the malformations.
How many clinical trials are available for Hereditary Haemorrhagic Telangiectasia?
RareWays currently indexes 55 clinical trials for Hereditary Haemorrhagic Telangiectasia, of which 8 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Hereditary Haemorrhagic Telangiectasia come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Hereditary Haemorrhagic Telangiectasia.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.